GBT   $68.49  0.01% Market Closed

Last Events:

2022-10-05 Trend pattern changed from канал to восходящий клин.

2022-10-04 Signal in Stochastic changed from bearish reversal to bullish recovery. The stochastic indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.

2022-10-01 Signal in Stochastic changed from bullish to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2022-10-01 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2022-09-29 Trend pattern changed from восходящий клин to канал.

2022-09-29 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: entrance to the overbought zone.

2022-09-28 Trend pattern changed from сужающийся канал to восходящий клин.

2022-09-28 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: signal line crossed the middle level.


Current temperature: 0.11
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 50.88
Target: 65.00
High with 50% probability: 85.14
Analyst Recommendations:
Number of estimates 9
Target Price Mean 65.00
Mean unverified/preliminary 65.00 / 65.00
Target Price Low / High 49.00 / 68.50
Median / STD DEV 68.50 / 6.66
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy Sell
rsi ActivelyBuy - Sell
macd ActivelyBuy - -
stoch Buy Buy -
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternSept. 30, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US37890U1088
ceo Dr. Ted W. Love M.D.
Website https://www.gbt.com
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.